BMY Financial Facts
Dividends declared per common share: 0.38Earnings Before Income Taxes: 1.56B
See Full Income Statement
U.S. and foreign income taxes payable: 905M
Other liabilities: 1.64B
See Full Balance Sheet
Bristol-Myers Squibb Company (BMY) Earnings
|
Expand Research on BMY
| Next EPS Date | 4/25/24 | EPS Growth Rate | -21.5% |
|---|---|---|---|
| Average EPS % Beat Rate | +2.8% | Revenue Growth Rate | +1.5% |
| Average % Move 1-Wk after EPS | -3.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/25/19 |  |
Q219 | $1.18 | $1.06 | +$0.12 | $6.3B | $6.11B |  |
 | | Details |
10/27/16  |
|
Q316 | $0.77 | $0.65 | +$0.12 | $4.83B | $4.79B | |
| | Details |
| 10/27/15 |
|
Q315 | $0.39 | $0.35 | +$0.04 | $4.07B | $3.83B | |
| | Details |
| 4/27/17 | |
Q117 | $0.84 | $0.74 | +$0.10 | $4.93B | $4.72B | = | | | Details |
| 4/28/16 |
|
Q116 | $0.74 | $0.65 | +$0.09 | $4.39B | $4.19B | |
| | Details |
| 10/25/22 | Q322 | $1.99 | $0.00 | +$1.99 | $11.22B | N/A | = | | | Details | |
| 2/6/20 | |
Q419 | $1.22 | $0.94 | +$0.28 | $7.9B | $6.19B | = | | | Details |
| 2/2/23 | Q422 | $1.82 | $1.73 | +$0.09 | $11.4B | $11.21B | = | | | Details |
